<< Back to News

System Formulary Update
Sevelamer Carbonate (Renvela)

Situation:

Sevelamer carbonate (Renvela) 0.8 g packets for oral suspension was approved for addition to the UNC Health System Formulary at the April 2023 System Pharmacy and Therapeutics Committee meeting.

Background:

The following medications were reviewed: Sevelamer carbonate (Renvela) 0.8 g packets for oral suspension

Assessment/Recommendations:

System P&T voted to include the following product from the UNC Health Medication Formulary:

• Sevelamer carbonate (Renvela) 0.8 g packets for oral suspension

Note: Stock of this formulary product may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, April 9, 2024